Topical Pimecrolimus 1% Cream for Resistant Seborrheic Dermatitis of the Face An Open-Label Study


GÜLER ÖZDEN M., SOLAK TEKİN N., İLTER N. , Ankarali H.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, vol.11, no.1, pp.51-54, 2010 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 1
  • Publication Date: 2010
  • Doi Number: 10.2165/11311160-000000000-00000
  • Title of Journal : AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
  • Page Numbers: pp.51-54

Abstract

Background: Treatment options for seborrheic dermatitis are numerous, including both topical and systemic agents (e.g. topical corticosteroids, oral antifungals, and psoralen plus UVA). However, long-term use of topical corticosteroids may lead to adverse effects. Pimecrolimus 1% cream is an effective and well tolerated treatment for seborrheic dermatitis.